Follow @keithspeights
Recent articles
Better Buy: Aphria vs. Constellation Brands
Which stock wins in a head-to-head matchup between a leading Canadian cannabis producer and the top premium beer maker?
Is Biogen a Buy After the Biggest Biotech Bombshell in Years?
A drug once thought as dead could be rising from the ashes. Does Biogen's shocking news make the stock a buy now?
What You'll Want to Know About Centene's Terrific Q3 Results
Great revenue and earnings growth made investors happy with the health insurer's latest performance.
3 Things You'll Want to Know About Quest Diagnostics' Q3 Results
The diagnostics information services company beat expectations on both the top and bottom lines.
Why Gossamer Bio Stock Is Swinging Wildly Today
Investors weren't exactly sure how to react to the clinical failure of a drug that works similarly to Gossamer's lead candidate.
3 Beaten-Down Cannabis Stocks Likely to Bounce Back in a Big Way
These three cannabis stocks probably won't flounder for very much longer.
3 Stocks That Could Make You Rich
These stocks each have three secret ingredients for long-term investing success.
3 Stocks With Fast-Growing Dividends That Retirees Will Love
These solid companies have boosted their dividends by at least 67% over the last three years.
3 Reasons Aurora Cannabis Could Soar Before the End of 2019
Don't be surprised if the beaten-down Canadian marijuana stock makes a comeback soon.
Better Buy: Geron vs. Celgene
Which stock wins between these two biotechs?
Why Johnson & Johnson Stock Sank Today
A recall of its baby powder sparked worries about the healthcare giant's asbestos-related legal battles.
Why HEXO Stock Soared Today
Plans to launch cannabis-infused beverages lit a fire beneath the beaten-down marijuana stock.
3 Things You Should Expect With Canada's Cannabis 2.0 Recreational Marijuana Market
A potentially large new cannabis market is at hand in Canada. Here's what to look for.
Why Endo International Stock Is Skyrocketing Today
Investors are excited about the potential for a settlement in opioid litigation.
3 Things You'll Want to Know About Abbott Labs' Q3 Results
Here's a quick rundown on how the healthcare giant performed.
Better Marijuana Stock: Aurora Cannabis vs. Namaste Technologies
Which stock wins in a one-on-one matchup between a leading Canadian cannabis producer and a top e-commerce company serving the cannabis industry?
Crown Aphria the New King of Canadian Marijuana Stocks After Its Blowout Q1 Results
It's growing. It's profitable. It's beating expectations. The other big Canadian pot stocks aren't.
Why Aphria Shares Are Soaring Today
Impressive quarterly results are lighting a fire beneath this Canadian marijuana stock.
Forget Canopy Growth: Why 1 Top Analyst Likes Aphria and Aurora Cannabis Instead
All three of these top Canadian marijuana stocks are struggling. But a Jefferies analyst thinks that two out of three of them aren't bad.
The Marijuana Megadeal That Wasn't: What's Next for MedMen?
MedMen says its approach is to go deep rather than wide now that the PharmaCann buyout has been scrapped.